Equities

Seikagaku Corp

4548:TYO

Seikagaku Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)810.00
  • Today's Change-7.00 / -0.86%
  • Shares traded36.20k
  • 1 Year change+7.14%
  • Beta0.5819
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Seikagaku Corp had no change in net income (2.19bn) despite revenues that grew 8.24% from 33.46bn to 36.21bn. Year on year Seikagaku Corp had little change in net income (from 2.24bn to 2.19bn) despite revenues that grew 8.24% from 33.46bn to 36.21bn. A factor has been an increase in the cost of goods sold as a percentage of sales from 46.13% to 53.40%.
Gross margin47.98%
Net profit margin5.25%
Operating margin3.88%
Return on assets2.46%
Return on equity2.74%
Return on investment2.66%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Seikagaku Corp fell by 7.10bn. However, the company earned 514.00m from its operations for a Cash Flow Margin of 1.42%. In addition the company used 7.21bn on investing activities and also paid 1.46bn in financing cash flows.
Cash flow per share71.00
Price/Cash flow per share11.98
Book value per share1,379.48
Tangible book value per share1,316.78
More ▼

Balance sheet in JPYView more

Seikagaku Corp appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio6.11
Quick ratio4.53
Total debt/total equity0.0052
Total debt/total capital0.0051
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -1.01%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.56%
Div growth rate (5 year)0.00%
Payout ratio (TTM)75.78%
EPS growth(5 years)0.16
EPS (TTM) vs
TTM 1 year ago
68.62
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.